Patient-derived kidney organoids recapitulate ADPKD and facilitate the identification of Rho pathway inhibitors as candidate therapeutics
患者来源的肾脏类器官能够重现 ADPKD 的病理过程,并有助于鉴定 Rho 通路抑制剂作为候选治疗药物。
期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2026.102720
Guo, Liqiang; Fan, Yujia; Sun, Huixian; Du, Haoran; Xiong, Hui; Li, Yilin; Zhang, Xinyan; Guan, Yong; Ren, Lingtong; Wang, Xuan; Chen, Kai; An, Yachun; Zhang, Xiaohui; Mao, Yunuo; Gong, Yongfeng; Kong, Feng; Qiu, Jichuan; Chen, Rui; Shi, Benkang; Yi, Fan; Hu, Huili; Zhao, Shengtian